D-1842-2019 Class III Terminated
FDA drug recall D-1842-2019 was initiated by Aurobindo Pharma USA Inc. on Jul 29, 2019 and is designated Class III. Reason for recall: Labeling; Incorrect or Missing Lot and/or Exp Date; some bottles labeled with lot number 05318054B instead of 05318034B The recall status is terminated (terminated Oct 28, 2021). Affected quantity: 2,352/1000 count bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Sep 4, 2019
- Initiation Date
- Jul 29, 2019
- Termination Date
- Oct 28, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2,352/1000 count bottles
Product description
Simvastatin Tablets, USP 40 mg. Rx Only 1000 Count Bottles Manufactured by: Aurolife Pharma LLC Dayton NJ 08810 Manufactured for: Aurobindo Pharma USA, Inc. Dayton, NJ 08810 NDC 65862-053-99
Reason for recall
Labeling; Incorrect or Missing Lot and/or Exp Date; some bottles labeled with lot number 05318054B instead of 05318034B
Distribution pattern
Product was distributed nationwide by three major distributors who may have further distributed the product.
Code information
05318054B, exp 3/2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1842-2019
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026